These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 14589)

  • 1. [Optimization of conditions for determining the activity of amphotericin B].
    Bershteĭn EM
    Antibiotiki; 1977 Jan; 22(1):13-6. PubMed ID: 14589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of certain factors on the determination of the biological activity of amphotericin B].
    Mogilevskaia EM
    Antibiotiki; 1975; 20(12):1069-73. PubMed ID: 773282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the nutrient medium components on the formation of growth inhibition zones of the test microbe in determining the biological activity of mycoheptin].
    Vasil'eva NG; Fradkova TA
    Antibiotiki; 1979 Mar; 24(3):185-9. PubMed ID: 36026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spectrophotometric analysis of amphotericin B in technological objects].
    Bershteĭn IIa; Vlasenko AIu; Bershteĭn EM; Vekshin GA
    Antibiotiki; 1984 Jan; 29(1):19-24. PubMed ID: 6696398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media].
    Alp S; Sancak B; Arikan S
    Mikrobiyol Bul; 2008 Apr; 42(2):293-300. PubMed ID: 18697427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2070-4. PubMed ID: 11408225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of amphotericin B on the enzyme system of Candida albicans].
    Mikhaĭlova NG; Araviĭskiĭ RA
    Antibiotiki; 1977 May; 22(5):426-8. PubMed ID: 327912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nutrient medium for determining the biological activity of heliomycin].
    Bershteĭn EM; Vasil'eva NG; Poliak MS; Grigor'eva VM; Astanina LN
    Antibiotiki; 1984 Oct; 29(10):766-70. PubMed ID: 6439107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
    Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the cultivation conditions of Candida species yeast-like fungi on their sensitivity to levorin].
    Vasil'eva NG; Fradkova TA; Golubkova LS
    Antibiotiki; 1977 May; 22(5):433-7. PubMed ID: 327914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amphotericin B alone or in combination with rifampicin on phagocytosis of Candida species by human polymorphonuclear leukocytes.
    Schaumann RF; Shah PM
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):753-8. PubMed ID: 1297891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standardization of the nutrient medium for determining the biological activity of a number of antibiotics by the diffusion-in-agar method].
    Bershteĕin EM; Vasil'eva NG; Poliak MS
    Antibiotiki; 1983 Apr; 28(4):250-4. PubMed ID: 6407390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the pH of the medium on the growth and chemical composition of the methanol-assimilating yeast Candida boidinii].
    Podgorskiĭ VS
    Mikrobiologiia; 1981; 50(6):1084-7. PubMed ID: 7329355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
    Mignini F; Prenna M; Oliveri S; Cammarata E; Falcioni E; Dainelli B; Ripa S
    Chemioterapia; 1988 Feb; 7(1):38-41. PubMed ID: 3378274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].
    Carrillo-Muñoz AJ; Santos P; del Valle O; Casals JB; Quindós G
    Rev Esp Quimioter; 2004 Sep; 17(3):244-9. PubMed ID: 15619653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
    Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
    Chryssanthou E; Sjölin J
    J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B susceptibility of Candida species assessed by rapid flow cytometric membrane potential assay.
    Ordóñez JV; Wehman NM
    Cytometry; 1995 Jun; 22(2):154-7. PubMed ID: 7587748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.